China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
CPHI stock price ended at $0.88 on 星期三, after rising 2.33%
On the latest trading day Jun 03, 2026, the stock price of CPHI rose by 2.33%, climbing from $0.82 to $0.88. During the session, the stock saw a volatility of 12.82%, with prices oscillating between a daily low of $0.78 and a high of $0.88. Notably, trading volume dropped by 9.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 45.9K shares were traded, equating to a market value of approximately $35.6M.